###begin article-title 0
The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
Trafficking of corneal antigen-presenting cells (APC) to draining lymph nodes (LN) is critical in triggering immune responses. However, very little is known about the molecular regulation of this pathway. We investigated the expression and function of the chemokine receptor CCR7 in mediating corneal APC migration in inflammation.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 458 459 458 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 702 703 702 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Expression of CCR7 and its ligands, CCL21 and CCL19, in the normal and inflamed corneas was analyzed by RT-PCR and immunofluorescence staining. The phenotype of CCR7-expressing cells was identified by double-staining with different cell surface markers. To trace the trafficking of APC to draining LN, we injected corneal grafts with Alexa488-conjugated ovalbumin (OVA) and transplanted to syngeneic recipients. CCR7 expression on the Alexa488-conjugated OVA+ cells in the ipsilateral draining LN was analyzed by flow cytometry. To determine the functional role of CCR7, we injected anti-CCL21 neutralizing antibody subconjunctivally after corneal transplantation and analyzed changes in numbers of OVA+ cells in the draining LN. Each experiment was repeated at least three times.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 141 142 141 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 210 211 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 235 236 235 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 265 266 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 271 272 271 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 537 538 537 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 682 683 682 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 688 689 688 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Both CCR7 and its ligand CCL21 were significantly upregulated in inflamed corneas as measured by RT-PCR and immunofluorescence staining. CCR7+ cells were detected especially in the corneal periphery near LYVE-1+ lymphatic vessels. CCR7+ cells were universally CD11b+CD11c+, and a majority were major histocompatibility complex class II positive, suggesting a monocytic dendritic cell lineage and a relative state of maturation. Forty-eight h after syngeneic transplantation with OVA-loaded grafts, CCR7 expression was detected on the OVA+ cells in both the host corneal beds and the draining LN. Local administration of anti-CCL21 led to a significant suppression in the flow of OVA+CD11c+ cells to the draining LN.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
These data suggest that in inflammation, APC expressing CCR7 on their cell surface interact with CCL21 to facilitate their migration from the cornea to draining LN via afferent lymphatics.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 837 838 837 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 839 840 839 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 1068 1069 1068 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
During the past decade, peripheral tissue dendritic cells (DC) have been credited as the principal antigen-presenting cells (APC) in activating naive T cells within secondary lymphoid tissues (e.g., lymph nodes [LN]) [1]. As such, DC are critical in immune surveillance in infectious diseases, cancer, transplantation, and allergy. Recent data from our laboratory have revealed that mature DC in the inflamed cornea, including both resident cells and those recruited from the vascularized areas around the cornea, including the limbus and conjunctival lymphatics, traffic to draining LN through the afferent lymphatics. Mature DC that express high levels of major histocompatibility complex (MHC) class II and B7 (CD80/CD86) costimulatory molecules can thus stimulate naive T cells in the draining LN to induce immunogenic inflammation [2-5]. Disruption of this eye-LN axis (e.g., through surgical cervical and submandibular lymphadenectomy) has been shown to lead to both complete abrogation of host allosensitization and universal and indefinite allograft survival [6]. Therefore, determining the regulatory mechanisms of DC trafficking is a key issue in corneal immunology. Recently, we have been interested in using molecular strategies to nonsurgically sever the APC-lymphatic access, an approach we have termed "molecular lymphadenectomy".
###end p 11
###begin p 12
###xml 249 250 249 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
Our previous work has shown that signaling through vascular endothelial growth factor receptor-3 (VEGFR-3) is critical for DC access to lymphatics, and that selective blockade of this can impair DC flow to draining LN and induction of alloimmunity [7,8]. However, VEGFR-3-based interventions have effects beyond APC trafficking: Sprouting blood and lymphatic vessels express VEGFR-3, and blockade of VEGFR-3 can eventually also alter hemangiogenic and lymphangiogenic responses [9]. Additionally, corneal epithelial VEGFR-3 has recently been shown to be an important "sink" mechanism for VEGF-C/D, suppressing their ligation of VEGFR-2, and hence angiogenesis [10]. Therefore, VEGFR-3 targeting is not wholly specific to APC trafficking. Thus, we have continued our search for other molecular mechanisms involved in regulation of DC trafficking.
###end p 12
###begin p 13
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 497 499 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 500 502 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 794 796 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 797 799 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 698 702 <span type="species:ncbi:10090">mice</span>
CC chemokine receptor 7 (CCR7) is a receptor thought to be critical for the colocalization of mature DC and T cells in the local draining LN in several tissues [11-18]. Both CCR7 ligands, CCL19 (also known as macrophage inflammatory protein 3-beta, MIP-3beta), and CCL21 (also known as secondary lymphoid tissue chemokine, SLC), are expressed in the T-cell zones of secondary lymphoid organs. In addition, CCL21 is expressed by endothelial cells in lymphatic vessels and high endothelial venules [19,20]. Therefore, CCR7-mediated DC migration, guided by CCL19 and CCL21, results in accumulation of mature DC in the afferent lymphatics and the T-cell areas of draining LN. Studies in CCR7-deficient mice have revealed a marked defect in DC migration to LN and impaired primary immune responses [11,18]. However, the expression and function of CCR7 and their ligands in the inflamed cornea have not been reported to date. We therefore hypothesized that CCR7 and its ligands are essential for DC migration from the cornea to the draining LN.
###end p 13
###begin p 14
The specific aim of this study was to examine the expression of CCR7 and its ligands in the inflamed cornea, and determine their effect on DC trafficking from the inflamed cornea to the draining LN using an OVA-loaded corneal graft model. The results demonstrated that migration of DC is facilitated by the interaction of the CCR7 expression on their surface with CCL21 secreted by the lymphatic vessels.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Animals
###end title 16
###begin p 17
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Six- to eight-week-old male BALB/c (Taconic Farms, Germantown, NY) mice were used in all experiments. The animals were anesthetized with a Katamine (120 mg/Kg BW) and Xylazine (20 mg/Kg BW) mixture before all surgical procedures. Carbon dioxide inhalation was applied to euthanize the animal before we harvested cornea and LN. All experimental protocols were approved by the Schepens Eye Research Institute Animal Care and Use Committee, and all animals were treated according to the Association for Research in Vision and Ophthalmology statement for the Use of Animals in Ophthalmic and Vision Research.
###end p 17
###begin title 18
Suture-induced inflamed cornea
###end title 18
###begin p 19
###xml 324 326 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
Three interrupted sutures (11-0 nylon, Sharpoint; Vanguard, Houston, TX) were placed intrastromally with two stromal incursions extending over 120degrees of the corneal circumference. This procedure has been demonstrated to induce inflammatory corneal neovascularization, also associated with significant lymphangiogenesis [21]. After 10 days, when all corneas developed extensive neovascularization, all sutures were removed. Then corneas were carefully dissected by Vannas scissors around limbus for RNA isolation and immunohistochemical studies, to ensure that the conjunctival and iris tissues were not included.
###end p 19
###begin title 20
RNA isolation and reverse transcriptase-PCR
###end title 20
###begin p 21
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
Corneas were harvested from the normal and inflamed mouse groups. Five corneas were involved in each group. To further dissect corneal epithelial and stromal-endothelial layers, another 5 corneas from inflamed mice were used. Each experiment was repeated three times. To extract mRNA from corneal epithelial and stroma-endothelial layers separately, five intact corneas were placed in 30 mul of RNA stabilization reagent (RNAlater, Qiagen, Valencia, CA) and then incubated in 250 mul of 20 mM EDTA (pH 7.4) at 37 degreesC for 30 min. Before mRNA isolation, the epithelial layers were peeled away from the stroma-endothelial layers. A combined method for total RNA isolation was employed, using Trizol (Invitrogen Corp., Carlsbad, CA) for tissue homogenization on ice, precipitation of RNA in the aqueous phase using 70% ethanol, followed by subsequent extraction and purification using RNeasy MinElute Spin Columns (Qiagen). Reverse transcription of total RNA was conducted using oligo(dT)15 primer and Sensiscript Reverse Transcriptase (Qiagen, Hilden, Germany). PCR was conducted using primer pairs for CCR7 (sense GAG GAA AAG GAT GTC TGC CAC G, antisense GGC TCT CCT TGT CAT TTT CCA G, 284 bp), CCL21 (sense CCA AGT TTA GGC TGT CCC ATC, antisense GGG CTA CTG GGC TAT CCT CT, 257 bp), CCL19 (sense CCT TCC GCT ACC TTC TTA ATG, antisense CTT CTG GTC CTT GGT TTC CTG, 229 bp), CXCR3 (sense CGC AAC TGT GGT CGA GAA AGC, antisense CAC AGG GAT GGC TGA GTT CTA C, 525 bp) and GAPDH (sense GAA GGG CAT CTT GGG CTA CAC, antisense GCA GCG AAC TTT ATT GAT GGT ATT, 373 bp). The PCR conditions were 35 cycles at 95 degreesC for 30 s, 58 degreesC for 30 s, and 72 degreesC for 1 min, followed by final extension at 72 degreesC for 10 min. The size of PCR products was determined by agarose gel electrophoresis.
###end p 21
###begin title 22
Immunohistochemical studies
###end title 22
###begin p 23
###xml 1098 1103 <span type="species:ncbi:10090">mouse</span>
###xml 1150 1153 <span type="species:ncbi:10116">rat</span>
###xml 1291 1294 <span type="species:ncbi:10116">rat</span>
###xml 1358 1362 <span type="species:ncbi:9925">goat</span>
###xml 1429 1433 <span type="species:ncbi:9925">goat</span>
###xml 1478 1484 <span type="species:ncbi:9986">rabbit</span>
###xml 1571 1575 <span type="species:ncbi:9925">goat</span>
###xml 1710 1716 <span type="species:ncbi:9793">donkey</span>
###xml 1818 1823 <span type="species:ncbi:10090">mouse</span>
###xml 1847 1850 <span type="species:ncbi:10116">rat</span>
###xml 1876 1879 <span type="species:ncbi:10116">rat</span>
###xml 1905 1909 <span type="species:ncbi:9925">goat</span>
###xml 1955 1961 <span type="species:ncbi:9986">rabbit</span>
Full thickness corneal tissue or 8 mum frozen sections were fixed in 4% paraformaldehyde for 30 min at 4 degreesC or acetone for 15 min at room temperature (RT; n=5 per group per experiment, repeated three times). To prevent nonspecific staining, anti-FcR mAb (CD16/CD31, FcgammaIII/II receptor) and streptavidin/biotin blocking solutions (Vector Laboratories, Burlingame, CA) were used to block sections before they were stained with primary antibodies or isotype-matched control antibodies at 4 degreesC overnight. Thereafter, the tissues were incubated with secondary antibodies at RT. For visualization of CCR7 staining, tyramide amplification was used according to the manufacturer's instructions (PerkinElmer Life Sciences, Boston, MA). Each step was followed by three thorough washings in PBS for 5-10 min. Finally, the samples were covered with mounting medium (Vector Laboratories) and analyzed by confocal laser scanning microscope (TCS 4D; Leica, Heidelberg, Germany) or epifluorescence microscope (Eclipse E800; Nikon, Tokyo, Japan). The following antibodies were used: FITC-conjugated mouse antimouse Iab (MHC class II), FITC-conjugated rat antimouse CD11b (a marker for granulocytes, monocytes, and macrophages), purified hamster antimouse CD11c (DC marker), biotin-conjugated rat antimouse CCR7 (eBioscience, San Diego, CA), biotin-conjugated goat antimouse CCL21 (R&D Systems, Minneapolis, MN), biotin-conjugated goat antimouse CCL19 (R&D Systems), and purified rabbit antimouse LYVE-1 (Abcam, Cambridge, MA). The secondary antibodies were Cy5-conjugated goat antihamster IgG (Jackson ImmunoResearch, West Grove, PA), Cy3-conjugated antibiotin IgG (Jackson ImmunoResearch), and FITC-conjugated donkey antirabbit IgG (Santa Cruz Biotechnology, Santa Cruz, CA). Isotype controls included FITC-conjugated mouse IgG2a, FITC-conjugated rat IgG2b, biotin-conjugated rat IgG2a, biotin-conjugated goat IgG (Santa Cruz Biotechnology), and purified rabbit IgG (Santa Cruz Biotechnology). Except where noted, primary antibodies and isotype-matched were purchased from BD Pharmingen (San Diego, CA).
###end p 23
###begin title 24
Syngeneic transplantation with ovalbumin-loaded corneal tissue
###end title 24
###begin p 25
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 482 484 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 485 487 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 949 951 946 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
Fluorescently labeled antigens are useful for detecting the migration of macrophages and DC in the eye [22,23]. In our study, we injected Alexa488-labeled OVA into corneal grafts to track their migration (n=6 per experiment, repeated three times). Intrastromal injection with 2 mul of 2 mug OVA-Alexa488 (Molecular Probes, Eugene, OR) dissolved in PBS, or PBS alone, was performed in BALB/c mice through the limbus toward the central cornea, using a previously described technique [24,25]. Briefly, a small tunnel from the corneal epithelium to the anterior stroma was created using a 33-gauge needle (Hamilton Company, Reno, NV). Another 33-gauge needle attached to a 10 mul Hamilton syringe was passed through the tunnel into the stroma for the injection. After 24 h, these OVA-loaded grafts were placed onto neovascularized BALB/c host corneal beds. Our experiments employed a method of orthotopic corneal transplantation described in reference [26]. Briefly, a 2 mm corneal button was excised from the donor animal and grafted onto a 1.5 mm recipient corneal bed. Eight 11-0 interrupted nylon sutures were placed to secure the graft. Syngeneic corneal grafts never undergo immune rejection.
###end p 25
###begin title 26
Ocular administration of anti-CCL21
###end title 26
###begin p 27
###xml 341 343 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 344 346 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 90 94 <span type="species:ncbi:9925">goat</span>
###xml 291 296 <span type="species:ncbi:10090">mouse</span>
BALB/c mice were randomized to receive either anti-CCL21 (R&D systems) or isotype control goat IgG (Jackson ImmunoResearch) by subconjunctival injection in a masked fashion (n=3 per group per experiment, repeated three times). The antibodies were administered at a dose of 10 mug/10 mul per mouse on day -1, 0, 1 of corneal transplantation [12,27].
###end p 27
###begin title 28
Flow cytometry
###end title 28
###begin p 29
###xml 662 663 662 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 669 670 669 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Cells were harvested and pooled from ipsilateral submandibular LN of BALB/c recipients (n=3 per group per experiment, repeated three times) at 48 h posttransplantation. Upon blockade by anti-FcR mAb, cells were labeled with PE-conjugated anti-CD11c (BD Pharmingen) and quantified. Staining for CCR7 was done with a chimeric CCL19-Fc fusion protein (eBioscience), with PE-conjugated antihuman IgG (Fc-specific, eBioscience). Cells were subsequently washed and analyzed using an Epics XL flow cytometer (Beckman Coulter, Fullerton, CA). The percentage of cell subpopulations was quantified by three measurements, and the average was recorded. The percentage of OVA+ CD11c+ cells in the total cells of the draining LN was calculated with respect to isotype control staining. Mean values for each group (n=3) were compared via a two-tailed Student's t-test (GraphPad Prism 4.0c, San Diego, CA). A p-value <0.05 was considered significant.
###end p 29
###begin title 30
Results
###end title 30
###begin title 31
CCR7 is expressed in the inflamed cornea
###end title 31
###begin p 32
###xml 187 196 187 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 324 333 324 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B</xref>
###xml 354 355 354 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 455 464 455 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1C</xref>
We initially investigated the expression of CCR7 in both the inflamed and the normal cornea by RT-PCR. CCR7 mRNA was detected in the inflamed cornea, but was absent in the normal cornea (Figure 1A). Further examination of the inflamed cornea revealed CCR7 mRNA in the stroma-endothelial layer, but not the epithelial layer (Figure 1B). Consistently, CCR7+ cells were shown by immunohistochemistry to localize only in the inflamed anterior corneal stroma (Figure 1C).
###end p 32
###begin p 33
###xml 236 237 236 237 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 296 297 296 297 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 492 493 492 493 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
CCR7 is expressed in the inflamed corneal stroma. CCR7 expression in the cornea was first tested by RT-PCR. Lymph nodes served as a positive control. CCR7 mRNA expression was only detected in the inflamed cornea and not the normal one (A), and further identified in the stroma-endothelial layer (B: str indicates the stromal layer and endo designates the endothelia layer). CCR7 expression was displayed in red and the nuclear stain DAPI in blue on the cross-sections of the inflamed cornea (C). In the panels, Ep indicates corneal epithelium and St designates corneal stroma. Epifluorescence microscopy, original magnification: X40.
###end p 33
###begin title 34
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
CCR7+ cells in the inflamed corneal stroma represent bone marrow-derived dendritic cells
###end title 34
###begin p 35
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 198 199 198 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 382 383 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 410 411 410 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 468 477 468 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2B</xref>
###xml 551 552 551 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 584 585 584 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 587 596 587 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2A</xref>
###xml 683 684 683 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 713 714 713 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 715 716 715 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
Our previous studies have shown that the inflamed corneal stoma is endowed with bone marrow-derived DC and macrophages in addition to keratocytes [3]. We used several antibodies to identify the CCR7+ cells and to characterize the cells in the corneal stroma that express this receptor. When double-staining was performed for CCR7 and CD11c in whole mount corneas, we found that CCR7+ cells were uniformly CD11c+ and mostly located in the peripheral cornea and limbus (Figure 2B). In addition, double-staining for CCR7 and CD11b indicated that the CCR7+ cells were also uniformly CD11b+ (Figure 2A). This is consistent with our previous findings that the corneal stromal DC were CD11b+ and of a monocytic lineage [2,3,25].
###end p 35
###begin p 36
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 256 257 256 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 414 415 414 415 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 436 437 436 437 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 458 459 458 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 506 507 506 507 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
CCR7 was expressed by CD11b+ and CD11c+ cells in inflamed corneal stroma. CD11b (left), CD11b (left), CD11c (middle), and major histocompatibility complex (MHC) class II (right) were displayed in green in the normal and inflamed whole-mounted stromas. CCR7+ cells (red) were only detected in the inflamed (top panels), not the normal (bottom panels) corneal stromas. These cells were costained with CD11b (yellow; A) and CD11c (yellow; B). A majority of CCR7+ cells also co-expressed MHC class II (yellow; C). Confocal microscopy, original magnification: X40.
###end p 36
###begin p 37
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 148 149 148 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 184 193 184 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2C</xref>
###xml 268 269 268 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 279 280 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 384 393 384 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2F</xref>
To characterize the maturational state of the CCR7+ stromal DC, we further performed double-staining for CCR7 and MHC class II. The majority of CCR7+ cells were MHC class II positive (Figure 2C). These results indicate that CCR7 is expressed by relatively mature CD11b+ and CD11c+ DC in the inflamed corneal stoma. In contrast, immature DC in the normal corneas did not express CCR7 (Figure 2F).
###end p 37
###begin title 38
CCR7 is expressed by the ovalbumin-presenting dendritic cells migrating from the cornea to the draining lymph nodes
###end title 38
###begin p 39
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 107 116 107 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A</xref>
###xml 458 459 458 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 467 476 467 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B</xref>
###xml 488 489 488 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 579 588 579 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3D</xref>
We assessed the migration of the CCR7+ corneal stromal DC in syngeneic OVA-Alexa488-loaded corneal grafts (Figure 3A). Once APC pick up these fluorescence-labeled OVA antigens in the corneal graft and present them on the cell surface, these APC can be detected by their green fluorescence. Forty-eight hours after OVA-loaded corneal grafts were transplanted onto syngeneic lymphatic-rich host corneal beds, we found fluorescence-labeled OVA picked up by CCR7+ cells (Figure 3B). These OVA+ cells expressed both CCR7 and CD11c on their cell surface as measured by flow cytometry (Figure 3D). These data confirmed that antigen-presenting DC egress from the cornea to the draining LN with persistent expression of CCR7 on their cell surface.
###end p 39
###begin p 40
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 186 187 186 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 219 220 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 380 381 380 381 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 437 438 437 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 543 544 543 544 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 602 603 602 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 641 642 641 642 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 478 482 <span type="species:ncbi:10090">Mice</span>
CCR7 was expressed on OVA+ cells in both the recipient corneal beds and the draining lymph nodes. OVA-loaded corneal grafts were transplanted into vascularized syngeneic recipient beds (A). After 48 h, a portion of CCR7+ cells (red) also expressed OVA (green) on their surface in the recipient stromal beds (costained as yellow). Confocal microscopy, original magnification: X40 (B). Draining lymph node (LN) cells were harvested and OVA+ cells were detected by flow cytometry. Mice with PBS-loaded corneal grafts served as negative controls (C). Flow cytometric expression of CD11c and CCR7 on the OVA+ cells in the draining LN is shown in D.
###end p 40
###begin title 41
CCL21 is expressed in the inflamed corneal stroma
###end title 41
###begin p 42
###xml 286 295 286 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4A</xref>
We first detected that CCL21 was significantly expressed in the inflamed cornea at mRNA level. However, CCL19 transcript was present only at a low level in the inflamed cornea. Additionally, CXCR3, another receptor for CCL21, was detected neither in the normal nor the inflamed cornea (Figure 4A).
###end p 42
###begin p 43
###xml 226 227 226 227 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 280 281 280 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 309 310 309 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 351 352 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 408 409 408 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 447 448 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 477 478 477 478 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
CCR7 and CCL21 were expressed around neo-lymphatic vessels in the vascularized corneas. Transcript of CCL21, but not CCL19 or CXCR3, was significantly expressed in the inflamed corneas. Lymph nodes served as positive control (A). In the inflamed corneal stromas, dendritiform CCR7+ cells (left, red) and CCL21+ cells (middle, red) were near the LYVE-1+ lymphatics (green). CCL21 also co-localized with LYVE-1+ lymphatics (middle, yellow). No CCL19+ cells were detected (right; B). Confocal microscopy, original magnification: X40.
###end p 43
###begin p 44
###xml 188 189 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 205 206 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 239 240 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 270 271 270 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 293 302 293 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4B</xref>
Immunohistochemical studies revealed that CCL21 colocalized with LYVE-1+ (lymphatic vessel endothelial receptor 1) lymphatics in the inflamed corneal stroma. Furthermore, dendritiform CCR7+ cells and CCL21+ cells were located around LYVE-1+ lymphatics. However, no CCL19+ cells were detected (Figure 4B).
###end p 44
###begin title 45
CCL21 blockade inhibits corneal dendritic cell trafficking to draining lymph nodes
###end title 45
###begin p 46
###xml 513 514 513 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 519 520 519 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 556 564 556 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5</xref>
To test the hypothesis that corneal DC trafficking is functionally effected by the interaction of CCR7 and CCL21, we blocked local CCL21 function via subconjunctival injection of anti-CCL21. Forty-eight h after transplantion of OVA-loaded corneal grafts to syngeneic host beds, total cells of the draining LN were harvested from either anti-CCL21 or isotype control IgG administration group. Compared with the isotype control IgG group, the group that received subconjunctival anti-CCL21 demonstrated 40% less OVA+CD11c+ cells in the draining LN (p <0.05; Figure 5).
###end p 46
###begin p 47
###xml 28 29 28 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 295 296 295 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 304 305 304 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 354 355 354 355 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 415 416 415 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 424 425 424 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 617 618 615 616 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
CCL21 blockade inhibited OVA+CD11c+ dendritic cell trafficking to the draining lymph nodes. Forty-eight h after syngeneic OVA-loaded corneal grafts were transplanted, recipient draining LN cells were harvested from either anti-CCL21 or isotype control IgG-treated groups. The percentage of CD11c+ and OVA+ cells was analyzed by two-color flow cytometry (A). The results are expressed as the mean percentage of CD11c+ and OVA+ cells+/-SEM of 3 measurements (the asterisk indicates a p <0.05). The p-value is determined using a two-tailed Student's t-test. The data are representative of three independent experiments (B).
###end p 47
###begin title 48
Discussion
###end title 48
###begin p 49
###xml 873 875 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 876 878 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 1042 1044 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 1045 1047 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 1198 1199 1194 1195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1209 1210 1205 1206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1768 1770 1764 1766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 983 993 <span type="species:ncbi:111938">gatekeeper</span>
Investigation of the molecular regulation of DC trafficking is critical for a better understanding of corneal immunity. However, the mechanisms that regulate APC egress from the cornea have not been well understood, although the critical molecular mechanisms that regulate APC infiltration into the inflamed cornea have been much more extensively studied. Similar to other inflamed tissues, the expression of inflammatory cytokines (IL-1 and TNF-alpha) and inflammatory chemokine receptors (CCR1, CCR2, CCR3, CCR5, and CXCR1) is involved first in recruitment of innate immune cells (e.g., PMNs), and later MHC class II-positive APC (including DC, Langerhans cells, monocytes, and macrophages) from the intravascular compartment and peripheral matrix (limbus) into the cornea, through coordinated upregulation of endothelial cell adhesion factors in the limbal vasculature [28-33]. It is generally accepted that the mobilization of DC from the periphery to the LN is regulated by the gatekeeper receptor CCR7, along with the maturation of DC [11-20]. However, studies of CCR7-mediated DC migration from the cornea to the draining LN are lacking. In this study, we identified CCR7 expression on CD11b+ and CD11c+ DC in inflamed anterior corneal stroma. In our syngeneic OVA-loaded corneal graft model, both host and graft-derived DC were involved in antigen presentation. CCR7 expression on these DC was found either in the host beds or in the draining LN, indicating persistent CCR7 expression on these antigen-presenting cells during their trafficking. These data suggest that CCR7 expression is highly relevant to DC trafficking from the inflamed cornea to draining LN. Recent data suggest that CCR7 signaling may also be relevant for inhibiting mature DC apoptosis [34], but as of yet we have no data on this for the eye.
###end p 49
###begin p 50
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 411 412 411 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 449 450 449 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 547 548 547 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 691 693 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 776 777 776 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
Despite studies showing that CCR7 expression typically correlates with the upregulation of MHC and costimulatory molecule expression during DC maturation [9,13,14,35] there are stimuli, such as DNAX-activation protein 12 (DAP12), that can induce CCR7 expression by DC independently of their maturation and acquisition of MHC class II [36,37]. In our study, we found a small portion of MHC class II-negative CCR7+ cells, although the majority of CCR7+ cells were co-localized with MHC class II in the inflamed cornea. These relatively immature CCR7+ DC may have two different fates: (1) they may complete their maturation process under further maturation signals provided by CCL19 and CCL21 [38]; or (2) they may migrate into the draining LN in an immature state. Immature CCR7+ DC most likely will be poor in stimulating T cells and hence may induce immune tolerance [39]. Thus, the relationship between CCR7-mediated corneal DC trafficking and immune stimulation or tolerance induction is worthy of further study.
###end p 50
###begin p 51
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 313 314 313 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 332 333 332 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 344 345 344 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 626 627 626 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Although the cornea is lymphatic-free, lymphatic vessels can readily grow into it upon inflammatory stimulation [33]. Access of APC to the ipsilateral submandibular LN is facilitated by both these neolymphatic vessels in the corneal matrix and the normally present conjunctival lymphatics [4]. Our finding of CCR7+ DC close to CCL21+ and LYVE-1+ lymphatics suggests that CCL21-CCR7 interactions promote DC access to the lymphoid compartments. Moreover, the inhibitory effect of CCL21 blockade on antigen-bearing DC trafficking strongly supports the hypothesis that CCL21, secreted by lymphatic endothelial cells, promotes CCR7+ cell migration into the afferent lymphatics enroute to draining LN.
###end p 51
###begin p 52
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
Another ligand of CCR7 is CCL19, which is expressed by mature DC and stromal cells in the T cell zone of LN [40-43]. Although we only detected CCL19 mRNA (but not protein) expression levels in the inflamed cornea, this does not necessarily refute the contribution of CCL19 to corneal DC trafficking. This ligand may regulate DC trafficking after these cells migrate into the lymphatics or in the LN. However, we were not able to detect this in our experiments, and conclude that the function of CCL19, at least as it pertains to corneal DC trafficking, is not significant.
###end p 52
###begin p 53
###xml 1001 1002 1001 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 1207 1209 1207 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
One of the main challenges in immune modulation is to separate suppression of innate immunity that is critical for immediate host responsiveness to pathogens from T cell-mediated adaptive immunity that plays a critical role in the chronic destructive responses seen in a wide range of conditions, including transplant rejection and various forms of viral keratitis. One strategy that could potentially allow for this differential suppression of adaptive versus innate immunity is to devise interventions that specifically block egress of APC from the cornea to lymphoid reservoirs, but could leave intact the ingress of innate cells into the cornea. Our data here, demonstrating the role of CCR7 in regulating corneal DC trafficking to lymphoid tissues, suggest that CCR7 and CCL21 blockade could potentially offer one such venue for inhibiting the induction of T cell-mediated immunity. Obviously, this approach has more therapeutic benefit than surgical lymphadenectomy, as we described previously [6], to achieve immunologic ignorance. In our studies, however, CCL21 blockade only demonstrated up to 40% inhibitory effect on DC trafficking, similar to the inhibitory effect of CCL21 blockade on skin DC [11], suggesting that CCR7 may not be the exclusive mediator of DC migration from the cornea to lymphoid tissues. Further studies are necessary to determine the precise (overlapping, additive, or synergistic) relationship of VEGFR-3 and CCR7-mediated DC trafficking. Interestingly, CCL21 and VEGF-C, the ligands of CCR7 and VEGFR-3, respectively, are both expressed on lymphatic endothelia, suggesting a close relationship between DC trafficking and lymphangiogenesis in corneal inflammation.
###end p 53
###begin title 54
Acknowledgements
###end title 54
###begin p 55
We thank our colleagues Mr. Don Pottle of the Confocal Microscopy Unit and Dr. Randy Huang of the Flow Cytometry Unit at the Schepens Eye Research Institute for excellent technical assistance. This project was supported by grant EY-12963 from the National Institutes of Health and a research award (W81XWH-04-2-0008) from the Department of Defense (to M.R.D.).
###end p 55
###begin title 56
References
###end title 56
###begin article-title 57
Dendritic cells and the control of immunity.
###end article-title 57
###begin article-title 58
Corneal immunity is mediated by heterogeneous population of antigen-presenting cells.
###end article-title 58
###begin article-title 59
The corneal stroma is endowed with a significant number of resident dendritic cells.
###end article-title 59
###begin article-title 60
Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts.
###end article-title 60
###begin article-title 61
Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation.
###end article-title 61
###begin article-title 62
The critical role of lymph nodes in corneal alloimmunization and graft rejection.
###end article-title 62
###begin article-title 63
Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells.
###end article-title 63
###begin article-title 64
Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity.
###end article-title 64
###begin article-title 65
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling.
###end article-title 65
###begin article-title 66
Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.
###end article-title 66
###begin article-title 67
CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs.
###end article-title 67
###begin article-title 68
Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes.
###end article-title 68
###begin article-title 69
Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties.
###end article-title 69
###begin article-title 70
Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites.
###end article-title 70
###begin article-title 71
CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes.
###end article-title 71
###begin article-title 72
Modulation of dendritic cell trafficking to and from the airways.
###end article-title 72
###begin article-title 73
Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway.
###end article-title 73
###begin article-title 74
CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions.
###end article-title 74
###begin article-title 75
Dendritic-cell trafficking to lymph nodes through lymphatic vessels.
###end article-title 75
###begin article-title 76
Dendritic cell biology and regulation of dendritic cell trafficking by chemokines.
###end article-title 76
###begin article-title 77
Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis.
###end article-title 77
###begin article-title 78
Immunohistology of antigen-presenting cells in vivo: a novel method for serial observation of fluorescently labeled cells.
###end article-title 78
###begin article-title 79
Local retention of soluble antigen by potential antigen-presenting cells in the anterior segment of the eye.
###end article-title 79
###begin article-title 80
Rapid ocular angiogenic control via naked DNA delivery to cornea.
###end article-title 80
###begin article-title 81
In vivo gene delivery and visualization of corneal stromal cells using an adenoviral vector and keratocyte-specific promoter.
###end article-title 81
###begin article-title 82
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Orthotopic corneal transplantation in mice--evidence that the immunogenetic rules of rejection do not apply.
###end article-title 82
###begin article-title 83
Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis.
###end article-title 83
###begin article-title 84
Alterations in corneal stromal dendritic cell phenotype and distribution in inflammation.
###end article-title 84
###begin article-title 85
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
###end article-title 85
###begin article-title 86
###xml 94 116 <span type="species:ncbi:10298">herpes simplex virus 1</span>
Persistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simplex virus 1 infection.
###end article-title 86
###begin article-title 87
###xml 95 100 <span type="species:ncbi:9606">human</span>
High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo.
###end article-title 87
###begin article-title 88
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Analysis of corneal inflammation induced by cauterisation in CCR2 and MCP-1 knockout mice.
###end article-title 88
###begin article-title 89
Corneal antigen presentation: molecular regulation and functional implications.
###end article-title 89
###begin article-title 90
Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells.
###end article-title 90
###begin article-title 91
EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation.
###end article-title 91
###begin article-title 92
Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7.
###end article-title 92
###begin article-title 93
###xml 89 94 <span type="species:ncbi:9606">human</span>
DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells.
###end article-title 93
###begin article-title 94
Chemokines: more than just road signs.
###end article-title 94
###begin article-title 95
###xml 45 50 <span type="species:ncbi:9606">human</span>
Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin.
###end article-title 95
###begin article-title 96
Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages.
###end article-title 96
###begin article-title 97
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells.
###end article-title 97
###begin article-title 98
A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes.
###end article-title 98
###begin article-title 99
The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7.
###end article-title 99

